drugset / Press release
RAG-17: A Promising Novel Gene Silencing Therapy for SOD1-ALS Preliminary Safety and Efficacy Data from a First-in-Human Trial (Abstract)
2024-10-07 · Ractigen Therapeutics. · original ractigen.com ↗
Event: Society for Neuroscience Annual Meeting 2024 (Neuroscience 2024) (San Diego) View Abstract
The release as fetched from its publisher. ractigen.com ↗